Gerardo Rodríguez-Lobato, Hematologist at Hospital Clínic of Barcelona, shared a post on X:
“Exciting news CART and Myeloma research! Oriol Cardús presented outstanding results with our modified academic ARI2h CART with a CD28-TMD against multiple myeloma. This paves the way for more effective treatments! ”
Source: Gerardo Rodríguez-Lobato/X
